Received May 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC15 | PNEUMO (VAXNEUVANCE) | MERCK & CO. INC. | 1 | Y005465 | IM / RA |
On day of vaccination, patient developed erythema at injection site, along w/ swelling, warmth, pain, and decreased range of motion. Over next few days, these symptoms have improved, on day 4 after vaccination, does still have warmth, swelling, and tenderness at the site. Erythema resolved. Has also been itching throughout this time. Using benadryl and cool compresses. On the same day, the patient also developed an area of erythema on the left lower extremity. This reduced in size, but on day 3 after vaccination, a 1 cm blister developed in the center of the region of erythema. Unclear if this leg rash is related or coincidental
None
Asthma, allergies, anxiety
albuterol, adviar, fluoxetine, methocarbamol, vitamin D, vitamin E, prenatal vitamin, singulair, calcium
nuts, environmental, tree extract
None